Infinity Pharmaceuticals reported $51.59M in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Amgen AMGN:US USD 63.7B 4.41B
AstraZeneca AZN:LN USD 94.18B 2.39B
Bristol Myers Squibb BMY:US USD 98.2B 2.16B
Cytori Therapeutics CYTX:US USD 23.1M 1.83M
Eisai 4523:JP JPY 1.26T 11.59B
Eli Lilly And LLY:US USD 47.46B 397.9M
Genocea Biosciences GNCA:US USD 38.79M 17.18M
Gilead Sciences GILD:US USD 62.56B 313M
GlaxoSmithKline GSK:LN GBP 60.31B 28.73B
Infinity Pharmaceuticals INFI:US USD 51.59M 10.27M
Mirati Therapeutics MRTX:US USD 1.3B 23.29M
Novartis NOVN:VX USD 118.46B 4.45B
Seattle Genetics SGEN:US USD 3.62B 11.26M
Tg Therapeutics TGTX:US USD 217.89M 33.78M
Vascular Biogenics VBLT:US USD 35.53M 9.79M
YTE INCY:US USD 5.51B 191.18M